These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 8982627

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Optimum age of measles immunization--maternal and transplacentally transmitted measles antibodies in infancy.
    Mohan M, Mehta PK, Sehgal S, Prabhakar AK, Bhargava SK.
    Indian Pediatr; 1981 Sep; 18(9):631-5. PubMed ID: 7319611
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Transplacental measles immunity in infants in the 1st year of life].
    Bystriakova LV, Zaĭtseva RV, Kolobova LV, Pushkareva EA, Smorodinova IP.
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):50-2. PubMed ID: 1839342
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Serological evaluation of immunization against measles with 2 doses administered at 6 and 11 months of age: a prospective study].
    Pannuti CS, de Souza VA, Sato HK, Fink MC, Ribeiro MI, Hisi SK, Castelo A, de Mendonça JS.
    Rev Inst Med Trop Sao Paulo; 1990 Oct; 32(6):450-5. PubMed ID: 2135492
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The study of countermeasures on measles control in infants].
    Wang L, Sun L, Jiang Z, Kang S, Liu Y, Jiang X.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):49-50. PubMed ID: 11860845
    [Abstract] [Full Text] [Related]

  • 14. Measles antibodies in women and infants in the vaccine era.
    Kacica MA, Venezia RA, Miller J, Hughes PA, Lepow ML.
    J Med Virol; 1995 Feb; 45(2):227-9. PubMed ID: 7775944
    [Abstract] [Full Text] [Related]

  • 15. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA, Harry TO.
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [Abstract] [Full Text] [Related]

  • 16. Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review.
    Guerra FM, Crowcroft NS, Friedman L, Deeks SL, Halperin SA, Severini A, Hatchette TF, Bolotin S, Immunity of Canadians and Risk of Epidemics (iCARE) Network.
    Vaccine; 2018 Feb 28; 36(10):1248-1255. PubMed ID: 29398276
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines.
    Sabin AB, Flores Arechiga A, Fernández de Castro J, Sever JL, Madden DL, Shekarchi I, Albrecht P.
    JAMA; 1983 May 20; 249(19):2651-62. PubMed ID: 6341638
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.